Jhpiego

Jhpiego pledges support to countries working to eliminate cervical cancer

Retrieved on: 
Wednesday, March 6, 2024

Baltimore, Md., March 06, 2024 (GLOBE NEWSWIRE) -- On the eve of International Women’s Day, Jhpiego joined a historic wave of commitments to ending cervical cancer as a public health problem as part of the global Cervical Cancer Elimination Initiative meeting in Cartagena de Indias, Colombia .

Key Points: 
  • Baltimore, Md., March 06, 2024 (GLOBE NEWSWIRE) -- On the eve of International Women’s Day, Jhpiego joined a historic wave of commitments to ending cervical cancer as a public health problem as part of the global Cervical Cancer Elimination Initiative meeting in Cartagena de Indias, Colombia .
  • Jhpiego is also committed in supporting at least five other countries for HPV vaccine coverage improvement and/or implementation of tailored interventions to increase HPV vaccine coverage.
  • Jhpiego has long been committed to integrated programs that link improved screening and treatment for cervical cancer as well as accelerating vaccine uptake.
  • We are inspired by these new commitments to work together across the whole spectrum of cervical cancer responses; together we have the potential to save many more women’s lives.”

For healthy moms and babies: Jhpiego's climate-centric approach to ensure healthy futures

Retrieved on: 
Friday, November 3, 2023

As climate change makes people less healthy, Jhpiego's expertise in saving lives has never been more critical.

Key Points: 
  • As climate change makes people less healthy, Jhpiego's expertise in saving lives has never been more critical.
  • According to the World Health Organization, climate change is the single biggest threat facing humanity.
  • As it makes people less healthy, Jhpiego's expertise and experience in saving lives and improving health have never been more important.
  • Recent extreme weather events also exacerbate humanitarian crises, disconnecting millions of people from their health care providers, medicine, and facilities.

PharmaJet, Nigeria’s National Primary Health Care Development Agency, and Health-focused Consortium Begin Implementation of Study Using Tropis® ID for Routine Immunization

Retrieved on: 
Tuesday, October 24, 2023

Partners are also evaluating the acceptability and feasibility of using needle-free from the healthcare worker and caregiver perspective.

Key Points: 
  • Partners are also evaluating the acceptability and feasibility of using needle-free from the healthcare worker and caregiver perspective.
  • View the full release here: https://www.businesswire.com/news/home/20231024060890/en/
    Nigerian baby receiving polio vaccine with the PharmaJet Tropis® Precision Needle-free System.
  • Evidence from the study is intended to inform policy regarding intradermal delivery of polio vaccine in routine immunization settings.
  • Study preparation included the development of standard operating procedures to ensure congruence with the country’s existing medical guidelines.

Jhpiego CEO Honored with Prestigious Fellowship Award from Academy of Public Health

Retrieved on: 
Friday, October 13, 2023

Dr. Mancuso, the president and CEO of Jhpiego, and the other fellowship award recipients were honored as “individuals who have demonstrated exceptional leadership, scholarship, and service in the field of public health,” according to the award announcement released by the academy, which represents the membership of the West African Institute of Public Health.

Key Points: 
  • Dr. Mancuso, the president and CEO of Jhpiego, and the other fellowship award recipients were honored as “individuals who have demonstrated exceptional leadership, scholarship, and service in the field of public health,” according to the award announcement released by the academy, which represents the membership of the West African Institute of Public Health.
  • “For 50 years, Jhpiego has worked closely with health leaders across the African continent to ensure women, men, and their families receive high-quality health services.
  • “Thank you, Academy of Public Health, for this honor.”
    Dr. Mancuso, a recognized international business executive and nurse, has led Jhpiego for more than two decades.
  • “Your expertise and passion will undoubtedly continue to inspire the next generation of public health professionals and
    drive positive change in our region,” the academy announcement said.

Jhpiego, Johns Hopkins affiliate, rated "very high performer" on gender issues

Retrieved on: 
Thursday, July 13, 2023

In each of the previous three years, GH5050, an independent research initiative at the University College London Centre for Gender and Global Health, recognized Jhpiego as a “high performer.” Founded 50 years ago, Jhpiego, a Johns Hopkins affiliate, works in more than 40 countries worldwide.

Key Points: 
  • In each of the previous three years, GH5050, an independent research initiative at the University College London Centre for Gender and Global Health, recognized Jhpiego as a “high performer.” Founded 50 years ago, Jhpiego, a Johns Hopkins affiliate, works in more than 40 countries worldwide.
  • The Global Health 50/50 Report reviews publicly available, gender-related policies and practices of 197 organizations active in the global health sphere.
  • “This year’s very high rating from GH5050 showcases that Jhpiego’s commitment to gender equality in the workplace is all encompassing.
  • The GH5050 2023 report has been publishing reports on global health and gender since 2018 to advance action and accountability for gender equality in global health.

New Coalition Launched to Fight Breast and Cervical Cancers Across Asia-Pacific

Retrieved on: 
Thursday, June 1, 2023

SINGAPORE, June 1, 2023 /PRNewswire/ -- Crowell & Moring International is joining forces with Roche, TogetHER for Health, CAPED and Jhpiego to raise awareness about the surge of breast and cervical cancer cases in the Asia-Pacific region by founding the Asia-Pacific Women's Cancer Coalition.

Key Points: 
  • The coalition seeks to drive change throughout the region and highlight the innovations and solutions with the highest potential to reduce incidence and mortality associated with breast and cervical cancers among women.
  • Cancer is the second-leading cause of death around the world, and breast and cervical cancer are the leading causes of cancer deaths among women.
  • Together, let us prioritize the health and well-being of women everywhere, ensuring that no one is left behind in the fight against cervical and breast cancer," said Mridu Gupta , CEO of CAPED.
  • The Coalition seeks to promote domestic implementation of the principles and strategies set out in the WHO's cancer initiatives1.

PharmaJet, Nigeria's National Primary Health Care Development Agency and Health-focused Consortium Launch Assessment of the PharmaJet Tropis Vaccine Delivery System

Retrieved on: 
Tuesday, March 7, 2023

PharmaJet and co-investigators from the National Primary Health Care Development Agency (NPHCDA), Jhpiego , PATH and the Sydani Group met in Lagos Nigeria and have finalized the study design, outlined the timelines, protocol, and tools for the study.

Key Points: 
  • PharmaJet and co-investigators from the National Primary Health Care Development Agency (NPHCDA), Jhpiego , PATH and the Sydani Group met in Lagos Nigeria and have finalized the study design, outlined the timelines, protocol, and tools for the study.
  • It will assess the health impact, cost, and feedback from providers and caregivers of using Tropis for ID delivery of inactivated poliovirus vaccine (IPV) compared to standard intramuscular delivery using needle and syringe.
  • The PharmaJet Tropis NFIS is a WHO prequalified, hand-held device that delivers precise ID injections without needles.
  • “We are thrilled to be working with NPHCDA, Jhpiego, PATH, and Sydani on this study,” noted Paul LaBarre, Vice President of Global Business Development, PharmaJet.

Jhpiego Presents Global Humanitarian Awards to Shawn and Serena Levy and Hasan Minhaj and Dr. Beena Patel Minhaj

Retrieved on: 
Wednesday, December 7, 2022

Shawn and Serena Levy, Hasan Minhaj, and Dr. Beena Patel Minhaj were honored at Jhpiego's gala.

Key Points: 
  • Shawn and Serena Levy, Hasan Minhaj, and Dr. Beena Patel Minhaj were honored at Jhpiego's gala.
  • "Where every couple can decide if and when they want to have a child," she said.
  • "Where every teenager is armed with the knowledge they need to make healthy choices for their body and their future.
  • Jhpiego's Indrani Kashyap, a global health professional, shared the innovative work underway in India, her home country, and the progress to date.

Jhpiego to Present Global Humanitarian Awards to Shawn and Serena Levy and Hasan Minhaj and Dr. Beena Patel Minhaj

Retrieved on: 
Tuesday, November 8, 2022

Jhpiego, a Johns Hopkins affiliate, believes that where a woman and her family live should not determine if they live.

Key Points: 
  • Jhpiego, a Johns Hopkins affiliate, believes that where a woman and her family live should not determine if they live.
  • "The work that Jhpiego does, the ways in which this organization is changing lives, is bettering lives, aligns with the values that Serena and I hold," said Shawn.
  • "We're honored to be able to bring awareness to public health initiatives through both creative and grassroots mediums," said Beena.
  • For more information about Jhpiego and its annual gala, visit www.jhpiego.org or contact Ann LoLordo, 443.831.3834, [email protected] .

On World Polio Day 2022, PharmaJet Announces $1.5 million Grant From USAID to Evaluate Use of Needle-Free Delivery in Routine Polio Immunization

Retrieved on: 
Monday, October 24, 2022

The project will measure vaccine coverage and cost using Tropis ID for fractional inactivated poliovirus vaccine (IPV) delivery compared to standard intramuscular delivery using needle and syringe (N/S).

Key Points: 
  • The project will measure vaccine coverage and cost using Tropis ID for fractional inactivated poliovirus vaccine (IPV) delivery compared to standard intramuscular delivery using needle and syringe (N/S).
  • A preferred approach by healthcare workers and patients1 is needle-free ID delivery using Tropis, which was developed with support from the World Health Organization (WHO) and Bill & Melinda Gates Foundation.
  • On this World Polio Day 2022, we restate our commitment to the Global Polio Eradication Initiative and we are pleased to receive this grant from USAID Development Innovation Ventures.
  • Their advocacy efforts have played a role in decisions by governments to contribute more than $10 billion to the effort.